Summerset Group (SUM) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
16 Jun, 2026Executive summary
Achieved record underlying profit of NZ$206.4m, up 8% on FY23, and net profit after tax of NZ$339.8m, with total revenue up 18% year-over-year to NZ$319.9m.
Delivered 1,238 total settlements/ORA sales, up 12% on FY23, and delivered 708 new homes under ORA.
Maintained high occupancy (94%) and resident satisfaction (97%), with improved staff retention to 81%.
Expanded land bank to 6,147 retirement homes and 1,396 care homes across New Zealand and Australia.
Opened first Australian village at Cranbourne North and flagship St Johns village in Auckland, with further expansion underway.
Financial highlights
Underlying profit rose 8% to NZ$206.4m; net profit after tax was NZ$339.8m, down 20% due to lower fair value movement of investment property.
Operating cash flows reached a record NZ$443.2m, up 11% year-over-year.
Total assets increased 16% to NZ$8.1b; net tangible assets per share rose 13% to NZ$12.53.
Realised development margin was 28.9%, slightly down from FY23 due to sales mix.
Final dividend declared at NZ13.2 cps, totaling NZ24.5 cps for FY24.
Outlook and guidance
FY25 build rate guidance: 600–650 units in New Zealand and 50–80 in Australia, similar to FY24.
Q1 2025 settlements expected to be in line with Q1 2024; sales contract rates up ~30% year-to-date.
Committed sales pipeline increased to 430 units in February 2025, up 21% from FY24.
Focus remains on cost control, improving cash flow, and leveraging a strong balance sheet.
Plans to continue growth in both New Zealand and Australia, with ongoing village developments and land acquisitions.
Latest events from Summerset Group
- Record underlying profit, robust sales, and strong Australian growth drive positive outlook.SUM
H2 202516 Jun 2026 - Net profit after tax surged 26% to $127.2m, with record sales and strong operational growth.SUM
H1 202516 Jun 2026 - Underlying profit up 3% to $89.9m, record sales, and expansion amid sector funding challenges.SUM
H1 202416 Jun 2026 - Strong profit growth, disciplined expansion, and robust governance marked the annual meeting.SUM
AGM 202621 Apr 2026 - Strong growth, stable dividends, and strategic expansion amid sector and funding challenges.SUM
AGM 202529 Nov 2025 - Record Q3 2025 occupation right sales and robust growth in care agreements drive strong outlook.SUM
Q3 2025 TU10 Oct 2025